ASOpeptideconjugate Oligonucleotide peptide conjugates (POCs) represent a groundbreaking class of hybrid molecules that are rapidly transforming the landscape of biomedicine and nanotechnology. These sophisticated constructs are formed by covalently linking a peptide moiety to an oligonucleotide, creating a synergistic combination of their individual properties. This fusion offers enhanced functionality, improved targeting capabilities, and novel applications, particularly in the realm of therapeutics. The chemistry of peptide-oligonucleotide conjugates is a rapidly evolving field, with ongoing research exploring innovative synthesis methods and expanding their potential uses.
At their core, oligonucleotide conjugates are designed to harness the unique strengths of both peptides and oligonucleotides. Oligonucleotides, such as DNA and RNA, are renowned for their specific base-pairing capabilities, making them ideal for applications like gene silencing and modulation of gene expression. However, their inherent instability and poor cellular uptake often limit their therapeutic efficacy. Peptides, on the other hand, are highly versatile biomolecules that can be engineered for specific targeting, cellular penetration, and even catalytic activity. By conjugating these two components, researchers aim to overcome the limitations of individual molecules and unlock new therapeutic avenues.Oligonucleotide-peptide conjugatesrepresent chimeric molecules comprising a nucleic acid moiety covalently linked to a peptide moiety.
The synthesis of peptide-oligonucleotide conjugates involves various strategies, with the point of attachment being a critical consideration. A peptide can be conjugated either at the base, 3'-, or 5'-position of the sugar unit, or even at the backbone of the oligonucleotide. This precise control over conjugation allows for fine-tuning of the conjugate's properties and function. For instance, peptide-oligonucleotide conjugation through methods like solid-phase synthesis, often through an amide bond, can yield high-quality products. While stepwise peptide-oligonucleotide conjugation through solid-phase peptide synthesis (SPPS) provides high yields, it may be limited to shorter peptides.Oligonucleotide conjugatescreate opportunities to deliver theoligonucleotideto a specific cell or tissue and to fine-tune 'drug-like' properties. More advanced techniques, such as native chemical ligation (NCL), are also being employed for synthesizing complex CPP-ASO conjugates, demonstrating the ongoing innovation in this area. Recent advancements even highlight catalytic approaches for the synthesis of peptide-oligonucleotide conjugates, emphasizing sustainable and efficient methodologies.2025年9月17日—The oligonucleotide–peptide conjugatesshow higher uptake in the outer layer of the kidney, also known as the cortex, compared to the parent ...
The applications of oligonucleotide peptide conjugates are diverse and expanding. One of the most significant areas is in the development of oligonucleotide conjugates for therapeutic applications. These hybrid molecules can significantly improve cellular uptake, a crucial factor for the delivery of therapeutic oligonucleotides作者:S Grijalvo·2010·被引用次数:22—Two different series of oligonucleotide–peptide conjugateshave been efficiently synthesized by stepwise solid-phase synthesis. First, oligonucleotides and .... For example, conjugation with peptides facilitates the penetration of modified oligonucleotides into cells, including bacterial cells, opening doors for novel antimicrobial strategies. Furthermore, peptide-oligonucleotide conjugates have shown promise as improved antisense agents, capable of interfering with RNA function and offering a new approach to treating genetic diseases. The targeting precision of peptides can be leveraged to deliver oligonucleotides directly to specific cells or tissues, minimizing off-target effects and enhancing therapeutic outcomes. Studies have demonstrated that oligonucleotide-peptide conjugates can exhibit higher uptake in specific tissues, such as the kidney cortex, compared to their unconjugated counterparts, highlighting their potential for targeted drug deliveryA Catalytic Approach for the Synthesis of Peptide ....
Beyond their therapeutic potential, peptide-oligonucleotide conjugates are also emerging as crucial building blocks in nanotechnologyPeptide-oligonucleotide conjugatesare molecular composites containing a nucleic acid moiety covalently linked to a polypeptide moiety. They serve many .... Their ability to self-assemble into higher-ordered, protein-like structures is of great interestPeptide-oligo conjugates – Custom Synthesis. This self-assembly of higher-ordered protein-like structures can lead to the creation of novel nanomaterials with applications in diagnostics, biosensing, and drug delivery systems. The modular nature of these conjugates allows for the design of intricate architectures with tailored properties.作者:M Dastpeyman·2021·被引用次数:15—In this study, we have exploited native chemical ligation (NCL) as an efficient strategy forsynthesizing CPP-ASO conjugates.
The field of peptide-oligonucleotide conjugation is characterized by continuous innovation作者:M Gras·2024·被引用次数:5—Peptide−oligonucleotide conjugates(POCs) are covalent architectures composed of a DNA or RNA molecules linked to apeptide.. Researchers are exploring various linker molecules and conjugation strategies to optimize the stability, efficacy, and delivery of these hybrid constructs作者:C Lou·2016·被引用次数:68—Here, we show the applicability of peptide–oligonucleotide conjugates forself-assembly of higher-ordered protein-like structures.. The development of peptide-oligonucleotide conjugates (POCs) that combine the specificity of oligonucleotides with the functionality of peptides is a testament to the power of molecular engineering. As research progresses, we can anticipate even more sophisticated peptide-oligonucleotide conjugates with a wider range of applications, further revolutionizing medicine and materials sciencePeptide Oligonucleotide Conjugate. The exploration of conjugation of oligonucleotides with lipids and peptides also signifies a growing interest in creating multifaceted conjugates for enhanced therapeutic outcomes.
Join the newsletter to receive news, updates, new products and freebies in your inbox.